stars 1 stars 2 stars 3

InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake. Fund-I made 8 investments during the period 2007-12 and has exited all 8 investments. ILSF-II is partially exited with 12 investments and 8 exits. ILSF-III is fully invested with 13 investments.

InvAscent Questions

The InvAscent annual revenue was $1 million in 2026.

Vishy Chebrol is the Co-Founder, Chief Investment Officer and Managing Director of InvAscent.

11 people are employed at InvAscent.

InvAscent is based in Hyderabad, Telangana.

The NAICS codes for InvAscent are [325, 3254, 32, 32541].

The SIC codes for InvAscent are [283, 28].

Top InvAscent Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users